Skip to content

INTERPACE BIOSCIENCES, INC.

IDXG

CIK 0001054102

← back to feed
Revenue (TTM)
$38.54M
−17.5% YoY Q1 May 2026
Net Income (TTM)
$2.64M
+266.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.02
+122.5% YoY Q1 May 2026
Gross Margin
62.3%
Q1 May 2026
Operating Margin
9.4%
Q1 May 2026
Net Margin
6.8%
Q1 May 2026
Free Cash Flow (TTM)
$2.34M
Q1 May 2026
Cash
$2.65M
Q1 May 2026
Total Debt
$8.12M
Q1 May 2026
Shares Outstanding
27.7M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings